Undifferentiated Pleomorphic Sarcoma as an Uncommon Extracolonic Presentation in Lynch Syndrome with MLH1 Germline Mutation: A Case Study - Top-Institutions - MDSpire

Undifferentiated Pleomorphic Sarcoma as an Uncommon Extracolonic Presentation in Lynch Syndrome with MLH1 Germline Mutation: A Case Study

  • By

  • Yuxing Chen

  • Yilin Xiao

  • Ruihan Li

  • Mengjiao Wu

  • Yan Zong

  • Min Jin

  • Xiaona Chang

  • Hongli Liu

  • April 21, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Genetics
    • Oncology
    • Molecular Pathology
    • Sarcoma Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Genetic Counseling
    • Sarcoma Surgery
    • Molecular Diagnostics

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Cancer Genetics
    • Medical Oncology
    • Sarcoma Research
    • Molecular Pathology

  • #4

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Cancer Genetics
    • Translational Research
    • Immunotherapy
    • Rare Tumor Research

Original Source(s)

Undifferentiated Pleomorphic Sarcoma as an Uncommon Extracolonic Presentation in Lynch Syndrome with MLH1 Germline Mutation: A Case Study

  • by Yuxing Chen, Yilin Xiao, Ruihan Li, Mengjiao Wu, Yan Zong, Min Jin, Xiaona Chang, Hongli Liu

  • April 21, 2026

Related Content

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors

Management of locally advanced lynch syndrome rectal cancer during pregnancy with neoadjuvant immunochemotherapy: a case report

CD38+ NK cells: novel players in immunoregulation